blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2341918

EP2341918 - HERBAL FORMULATIONS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  04.01.2019
Database last updated on 21.01.2025
FormerThe patent has been granted
Status updated on  26.01.2018
FormerGrant of patent is intended
Status updated on  03.05.2017
FormerExamination is in progress
Status updated on  29.11.2016
Most recent event   Tooltip10.07.2020Lapse of the patent in a contracting state
New state(s): IS		published on 12.08.2020  [2020/33]
Applicant(s)For all designated states
LifeBiotic Medical Research Ltd
18 Feinstein St.
69123 Tel-Aviv / IL
[2018/09]
Former [2011/28]For all designated states
Life Biotech Medical Research Ltd
18 Fienstien St.
69123 Tel-Aviv / IL
Inventor(s)01 / MAIMON, Yair, N.
10 Shazar Street
52247 Ramat Gan / IL
 [2011/28]
Representative(s)Colombo, Stefano Paolo, et al
Marchi & Partners S.r.l.
Via Vittor Pisani, 13
20124 Milano / IT
[2018/09]
Former [2011/28]Colombo, Stefano Paolo, et al
MARCHI & PARTNERS S.r.l. Via G.B. Pirelli, 19
20124 Milano / IT
Application number, filing date09751979.724.09.2009
[2011/28]
WO2009IL00923
Priority number, dateUS20080136696P25.09.2008         Original published format: US 136696 P
[2011/28]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2010035262
Date:01.04.2010
Language:EN
[2010/13]
Type: A2 Application without search report 
No.:EP2341918
Date:13.07.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 01.04.2010 takes the place of the publication of the European patent application.
[2011/28]
Type: B1 Patent specification 
No.:EP2341918
Date:28.02.2018
Language:EN
[2018/09]
Search report(s)International search report - published on:EP27.05.2010
ClassificationIPC:A61K36/48, A61K36/65, A61K36/752, A61K36/8968, A61K36/076, A61K36/284, A61K36/815, A61K36/536, A61K36/23, A61K36/748, A61K36/258, A61K36/481, A61K36/638, A61P7/06, A61P1/08, A61P39/00
[2017/20]
CPC:
A61K36/00 (EP,US); A61K36/8968 (US); A61K31/337 (EP,US);
A61K31/513 (EP,US); A61K31/664 (EP,US); A61K31/704 (EP,US);
A61K36/076 (US); A61K36/23 (US); A61K36/258 (US);
A61K36/284 (US); A61K36/481 (US); A61K36/486 (US);
A61K36/536 (US); A61K36/539 (US); A61K36/638 (US);
A61K36/65 (US); A61K36/748 (US); A61K36/752 (US);
A61K36/815 (US); A61K45/06 (US); A61K9/0053 (US);
A61K9/20 (US); A61K9/48 (US); A61P1/08 (EP);
A61P35/00 (EP); A61P39/00 (EP); A61P43/00 (EP);
A61P7/06 (EP) (-)
C-Set:
A61K36/00, A61K2300/00 (EP,US)
Former IPC [2011/28]A61K36/48, A61K36/65, A61K36/752, A61K36/8968, A61K36/076, A61K36/284, A61K36/815, A61K36/536
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2018/09]
Former [2011/28]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
Extension statesALNot yet paid
BANot yet paid
RSNot yet paid
TitleGerman:KRÄUTERFORMULIERUNGEN[2011/28]
English:HERBAL FORMULATIONS[2011/28]
French:FORMULATIONS À BASE D'HERBES MÉDICINALES[2011/28]
Entry into regional phase12.04.2011National basic fee paid 
12.04.2011Designation fee(s) paid 
12.04.2011Examination fee paid 
Examination procedure12.04.2011Examination requested  [2011/28]
09.11.2011Amendment by applicant (claims and/or description)
18.10.2013Despatch of a communication from the examining division (Time limit: M06)
17.04.2014Reply to a communication from the examining division
04.11.2014Despatch of a communication from the examining division (Time limit: M06)
04.05.2015Reply to a communication from the examining division
10.02.2016Despatch of a communication from the examining division (Time limit: M06)
12.08.2016Reply to a communication from the examining division
18.11.2016Despatch of a communication from the examining division (Time limit: M02)
12.01.2017Reply to a communication from the examining division
04.05.2017Communication of intention to grant the patent
30.08.2017Fee for grant paid
30.08.2017Fee for publishing/printing paid
30.08.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  18.10.2013
Opposition(s)29.11.2018No opposition filed within time limit [2019/06]
Fees paidRenewal fee
22.09.2011Renewal fee patent year 03
24.09.2012Renewal fee patent year 04
30.09.2013Renewal fee patent year 05
24.09.2014Renewal fee patent year 06
23.09.2015Renewal fee patent year 07
23.09.2016Renewal fee patent year 08
15.01.2018Renewal fee patent year 09
Penalty fee
Additional fee for renewal fee
30.09.201709   M06   Fee paid on   15.01.2018
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU24.09.2009
AT28.02.2018
CY28.02.2018
DK28.02.2018
FI28.02.2018
HR28.02.2018
LT28.02.2018
LV28.02.2018
MC28.02.2018
MK28.02.2018
SE28.02.2018
SI28.02.2018
SK28.02.2018
SM28.02.2018
TR28.02.2018
BG28.05.2018
NO28.05.2018
GR29.05.2018
IS28.06.2018
IE24.09.2018
LU24.09.2018
MT24.09.2018
CH30.09.2018
LI30.09.2018
[2020/33]
Former [2020/31]HU24.09.2009
AT28.02.2018
CY28.02.2018
DK28.02.2018
FI28.02.2018
HR28.02.2018
LT28.02.2018
LV28.02.2018
MC28.02.2018
MK28.02.2018
SE28.02.2018
SI28.02.2018
SK28.02.2018
SM28.02.2018
TR28.02.2018
BG28.05.2018
NO28.05.2018
GR29.05.2018
IE24.09.2018
LU24.09.2018
MT24.09.2018
CH30.09.2018
LI30.09.2018
Former [2020/28]HU24.09.2009
AT28.02.2018
CY28.02.2018
DK28.02.2018
FI28.02.2018
HR28.02.2018
LT28.02.2018
LV28.02.2018
MC28.02.2018
SE28.02.2018
SI28.02.2018
SK28.02.2018
SM28.02.2018
TR28.02.2018
BG28.05.2018
NO28.05.2018
GR29.05.2018
IE24.09.2018
LU24.09.2018
MT24.09.2018
CH30.09.2018
LI30.09.2018
Former [2020/16]AT28.02.2018
CY28.02.2018
DK28.02.2018
FI28.02.2018
HR28.02.2018
LT28.02.2018
LV28.02.2018
MC28.02.2018
SE28.02.2018
SI28.02.2018
SK28.02.2018
SM28.02.2018
TR28.02.2018
BG28.05.2018
NO28.05.2018
GR29.05.2018
IE24.09.2018
LU24.09.2018
MT24.09.2018
CH30.09.2018
LI30.09.2018
Former [2020/08]AT28.02.2018
CY28.02.2018
DK28.02.2018
FI28.02.2018
HR28.02.2018
LT28.02.2018
LV28.02.2018
MC28.02.2018
SE28.02.2018
SI28.02.2018
SK28.02.2018
SM28.02.2018
BG28.05.2018
NO28.05.2018
GR29.05.2018
IE24.09.2018
LU24.09.2018
MT24.09.2018
CH30.09.2018
LI30.09.2018
Former [2019/40]AT28.02.2018
CY28.02.2018
DK28.02.2018
FI28.02.2018
HR28.02.2018
LT28.02.2018
LV28.02.2018
MC28.02.2018
SE28.02.2018
SI28.02.2018
SK28.02.2018
SM28.02.2018
BG28.05.2018
NO28.05.2018
GR29.05.2018
IE24.09.2018
LU24.09.2018
CH30.09.2018
LI30.09.2018
Former [2019/33]AT28.02.2018
CY28.02.2018
DK28.02.2018
FI28.02.2018
HR28.02.2018
LT28.02.2018
LV28.02.2018
MC28.02.2018
SE28.02.2018
SI28.02.2018
SK28.02.2018
SM28.02.2018
BG28.05.2018
NO28.05.2018
GR29.05.2018
IE24.09.2018
LU24.09.2018
Former [2019/30]AT28.02.2018
CY28.02.2018
DK28.02.2018
FI28.02.2018
HR28.02.2018
LT28.02.2018
LV28.02.2018
MC28.02.2018
SE28.02.2018
SI28.02.2018
SK28.02.2018
SM28.02.2018
BG28.05.2018
NO28.05.2018
GR29.05.2018
LU24.09.2018
Former [2019/24]AT28.02.2018
CY28.02.2018
DK28.02.2018
FI28.02.2018
HR28.02.2018
LT28.02.2018
LV28.02.2018
MC28.02.2018
SE28.02.2018
SI28.02.2018
SK28.02.2018
SM28.02.2018
BG28.05.2018
NO28.05.2018
GR29.05.2018
Former [2019/13]AT28.02.2018
CY28.02.2018
DK28.02.2018
FI28.02.2018
HR28.02.2018
LT28.02.2018
LV28.02.2018
SE28.02.2018
SI28.02.2018
SK28.02.2018
SM28.02.2018
BG28.05.2018
NO28.05.2018
GR29.05.2018
Former [2018/52]AT28.02.2018
CY28.02.2018
DK28.02.2018
FI28.02.2018
HR28.02.2018
LT28.02.2018
LV28.02.2018
SE28.02.2018
SK28.02.2018
SM28.02.2018
BG28.05.2018
NO28.05.2018
GR29.05.2018
Former [2018/51]AT28.02.2018
CY28.02.2018
DK28.02.2018
FI28.02.2018
HR28.02.2018
LT28.02.2018
LV28.02.2018
SE28.02.2018
SK28.02.2018
BG28.05.2018
NO28.05.2018
GR29.05.2018
Former [2018/50]AT28.02.2018
CY28.02.2018
FI28.02.2018
HR28.02.2018
LT28.02.2018
LV28.02.2018
SE28.02.2018
SK28.02.2018
BG28.05.2018
NO28.05.2018
GR29.05.2018
Former [2018/40]AT28.02.2018
CY28.02.2018
FI28.02.2018
HR28.02.2018
LT28.02.2018
LV28.02.2018
SE28.02.2018
BG28.05.2018
NO28.05.2018
GR29.05.2018
Former [2018/37]CY28.02.2018
FI28.02.2018
HR28.02.2018
LT28.02.2018
NO28.05.2018
GR29.05.2018
Former [2018/35]CY28.02.2018
FI28.02.2018
HR28.02.2018
LT28.02.2018
NO28.05.2018
Cited inInternational search[I]CN101152382  ;
 [I]CN101066125  ;
 [I]WO0202607  (PHARMAGENESIS INC [US], et al) [I] 1-70 * abstract *;
 [I]US6340482  (JONES DENNIS [US]) [I] 1-70 * paragraph [0149] *;
 [I]US2002098249  (NO YONG IL [KR]) [I] 1-70 * paragraph [0019] *;
 [I]US2003211180  (CHENG YUNG-CHI [US], et al) [I] 1-70 * page 3, paragraphs 28, 26-27 *;
 [I]  - LV YAN ET AL, "[Study on effect of Astragalus membranaceus injection on hematopoiesis in anemic mice with myelosuppression]", MEDLINE, US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US, (200509), Database accession no. NLM16447871, XP002574794 [I] 1-70 * abstract *
 [I]  - DATABASE WPI, 0, Derwent World Patents Index, vol. 2008, no. 63, Database accession no. 2008-K48167, XP002575585 & CN101152382 A 20080402 (YIN K) [I] 1-70 * abstract *
 [I]  - DATABASE WPI, 0, Derwent World Patents Index, vol. 2008, no. 30, Database accession no. 2008-E27703, XP002575586 & CN101066125 A 20071107 (REN X) [I] 1-70 * abstract *
 [I]  - SHEN AI-YU ET AL, "Antioxidant and antiplatelet effects of Dang-Gui-Shao-Yao-San on human blood cells", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (2005), Database accession no. PREV200510244066, XP002574795 [I] 1-70 * abstract *
 [I]  - LIU LI-PENG ET AL, "Effects of Sheng-Mai Injection on the PRPP synthetase activity in BFU-Es and CFU-Es from bone marrows of mice with benzene-induced aplastic anemia", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (20010810), Database accession no. PREV200100436221, XP002574796 [I] 1-70 * abstract *
Examination   - TAIXIANG W ET AL, "Chinese medical herbs for chemotherapy side effects in colorectal cancer patients.", THE COCHRANE DATABASE OF SYSTEMATIC REVIEWS 2005, (2005), no. 1, ISSN 1469-493X, page CD004540
    - ZHANG M ET AL, "Chinese medicinal herbs to treat the side-effects of chemotherapy in breast cancer patients.", THE COCHRANE DATABASE OF SYSTEMATIC REVIEWS 2007, (2007), no. 2, ISSN 1469-493X, page CD004921
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.